Individualized prophylactic treatment of patients with hemophilia A to improve effectiveness and optimize product consumption on the example of octocog alpha and rurioctocog alpha... by A. G. Tolkushin, M. E. Holownia-Voloskova, N. L. Pogudina

Connect to this object online.

Ocrelizumab - a monoclonal antibody - in the treatment of adult patients with multiple sclerosis: a systematic review by D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin

Connect to this object online.

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review by D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, E. M. Olyushina, K. I. Polyakova, A. G. Fisun, M. G. Grinin, K. A. Kokushkin

Connect to this object online.